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Introduction: Data on the incidence of a hypercoagulable state in trauma, as measured by thromboelastometry
(ROTEM), is limited and the prognostic value of hypercoagulability after trauma on outcome is unclear. We aimed
to determine the incidence of hypercoagulability after trauma, and to assess whether early hypercoagulability has
prognostic value on the occurrence of multiple organ failure (MOF) and mortality.
Methods: This was a prospective observational cohort study in trauma patients who met the highest trauma level
team activation. Hypercoagulability was defined as a G value of ≥11.7 dynes/cm2 and hypocoagulability as a
G value of <5.0 dynes/cm2. ROTEM was performed on admission and 24 hours later.
Results: A total of 1,010 patients were enrolled and 948 patients were analyzed. Median age was 38 (interquartile
range (IQR) 26 to 53), 77% were male and median injury severity score was 13 (IQR 8 to 25). On admission, 7% of
the patients were hypercoagulable and 8% were hypocoagulable. Altogether, 10% of patients showed
hypercoagulability within the first 24 hours of trauma. Hypocoagulability, but not hypercoagulability, was associated
with higher sequential organ failure assessment scores, indicating more severe MOF. Mortality in patients with
hypercoagulability was 0%, compared to 7% in normocoagulable and 24% in hypocoagulable patients (P <0.001).
EXTEM CT, alpha and G were predictors for occurrence of MOF and mortality.
Conclusions: The incidence of a hypercoagulable state after trauma is 10% up to 24 hours after admission, which is
broadly comparable to the rate of hypocoagulability. Further work in larger studies should define the clinical
consequences of identifying hypercoagulability and a possible role for very early, targeted use of anticoagulants.Introduction
Major trauma is among the most common causes of
death worldwide. Whereas uncontrolled bleeding ac-
counts for 50 to 80% of mortality early following trauma
[1,2], multiple organ failure (MOF) is the most import-
ant cause of late mortality after trauma [1,3]. Traumatic
injury induces a hypocoagulable state, as a result of
acute traumatic coagulopathy (ATC) accompanied by
loss, consumption and dilution of coagulation factors
and fibrinolysis. Hypothermia, shock and acidosis further
amplify the derangement of the coagulation system [4].
In addition to reduced hemostatic potential, trauma can
also induce a hypercoagulable state [5-7]. Animal experi-
ments have shown that hypercoagulability can arise within* Correspondence: m.c.muller@amc.uva.nl
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unless otherwise stated.hours of the injury [8], a phenomenon confirmed in
humans [5,9]. However, uniform definitions of hypercoag-
ulability are lacking and effects of this hypercoagulable
state after trauma are not fully elucidated, with studies
showing conflicting results. An association with adverse
events such as an increased risk of venous thromboembol-
ism has been reported [7,10,11]. However, early hyperco-
agulability has also been associated with decreased early
mortality, which may suggest that hypercoagulability is a
functional response in order to reduce blood loss [9].
In sepsis, it has been demonstrated that hypercoagula-
bility, characterized by the formation of microthrombi
with concurrent protein C deficiency and impaired fi-
brinolysis, contributes to MOF and adverse outcome
[12,13]. Although sepsis and trauma are different en-
tities, the accompanying coagulopathies show similarities
and persistent protein C deficiency after trauma is also
associated with occurrence of MOF [14,15]. Shock andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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and if the patient survives the initial bleeding episode,
this can result in a procoagulant state. It is conceivable
that therapy of ATC may add to this endogenous re-
sponse, possibly resulting in an overshoot in coagulation
over time, with subsequent enhancement of hypercoagu-
lability and MOF.
Diagnosing hypercoagulability is complex. Thrombin
generation tests, or assessment of plasma levels of natural
anticoagulants, as protein C, are not readily available for
clinical use and not validated to detect hypercoagulability.
Thromboelastometry (ROTEM) provides real-time infor-
mation on all aspects of the coagulation system, includ-
ing the presence of hypercoagulability [16,17]. The use of
thromboelastometry to diagnose hypocoagulability in
trauma has frequently been explored in recent years
[18-21]. However, reports on the use of ROTEM to de-
tect a hypercoagulable state are scarce.
We aimed to study the incidence of early hypercoagu-
lability in multiple trauma patients and to establish
whether hypercoagulability is associated with the occur-
rence of MOF and mortality. In addition, as transfusion
strategies have shifted, we assessed whether transfusion
strategy influenced the occurrence of hypercoagulability.
Methods
Study design and patients
A prospective observational cohort study was conducted
in four level-1 trauma centers in London, Oxford, Oslo
and Amsterdam. This study is part of the Activation of
Coagulation and Inflammation in Trauma (ACIT) study,
an ongoing prospective observational multicenter study
in trauma patients. The ethics committees of the Aca-
demic Medical Center in Amsterdam, the Netherlands;
of the Oslo University Hospital, Oslo, Norway; of the
Royal London Hospital, London and of the John Radcliffe
Hospital, Oxford, United Kingdom, all reviewed and ap-
proved the study. Written informed consent was obtained
from all participating patients. All procedures have been
performed in accordance with the ethical standards laid
down in the 1964 Declaration of Helsinki and its later
amendments. Between January 2008 and March 2013, all
adult trauma patients (18 years and older) who met the
local criteria for highest trauma team level activation were
eligible for enrollment in the study. Patients were excluded
if arrival at the emergency department (ED) was >2 hours
following injury; >2,000 ml of intravenous fluid was ad-
ministered before ED admission; they were transferred
from another hospital or if they had burns covering >5%
of total body surface area. Patients were retrospectively ex-
cluded if they declined to give consent to use data, were
receiving anticoagulation (not including aspirin), or had
moderate or severe liver disease or a known bleeding
diathesis.Data collection
Data were prospectively collected on patient demograph-
ics, time from injury to arrival at the ED, mechanism of in-
jury (blunt or penetrating), presence of traumatic brain
injury, vital signs on arrival and 24 hours after injury and
amount of fluid and blood products within the first
24 hours of injury. Trauma severity was assessed using the
injury severity score (ISS) [22]. Furthermore, sequential
organ failure assessment (SOFA) scores, with Glasgow
coma scale to assess neurologic dysfunction, and mortality
rates after 28 days were obtained.
Thromboelastometry
Thromboelastometric variables were measured with
ROTEM (Tem International, Munich, Germany). Citrated
blood samples were drawn within 1 hour after arrival in
the ED and a second sample was collected 24 hours
(±2 hours) after admission. All samples were processed
within 1 hour. For EXTEM, 20 μL of 0.2 mol/L CaCl2
(star-tem™) and 20 μL of human recombinant tissue factor
(r EXTEM™) were added to a test vial. Subsequently
300 μL of the citrated blood sample was added. For
INTEM, 20 μL of 0.2 mol/L CaCl2 (star-tem™) and 20 μL
of partial thromboplastin phospholipid made of rabbit
brain and ellagic acid (in-tem™) were added as activator to
300 μL of blood in the test cuvette. The electronic pipette
program guided all test steps. For both assays, clotting time
(CT), clot formation time (CFT), maximum clot firmness
(MCF) and alpha angle were recorded. Total clot strength
was assessed by G as calculated according to the formula:
(5,000 × MCF)/100 - MCF and expressed as dynes/cm2
[16]. G has a curvilinear relation with MCF and reflects the
contribution of enzymatic and platelet components to the
hemostasis, hereby better reflecting hemostatic potential
than individual thromboelastometry parameters [7,23]. G
has been shown to be valuable in diagnosing hypo- and hy-
percoagulability [7,16,23]. Hypercoagulability was defined as
a G value of ≥11.7 dynes/cm2 and hypocoagulability as a G
value of <5.0 dynes/cm2 (values provided by manufacturer).
Outcome variables
Primary outcome was the occurrence of MOF, assessed
by the SOFA score, which reliably assesses organ failure
in trauma patients [24]. The score awards 0 (normal) to
4 (most abnormal) points for each organ system. MOF
was defined by a score of 3 points or more [3]. Second-
ary outcome was 28-day mortality. In addition, effect of
transfusion strategy (ratio of red blood cells (RBC) to
fresh frozen plasma (FFP)) on ROTEM profile and oc-
currence of hypercoagulability was determined.
Statistics
Continuous normally distributed variables are expressed
by their mean and standard deviation. Not normally
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interquartile (IQR) ranges and categorical variables are
expressed as n (%). ISS was treated as a continuous vari-
able. Groups are compared by using Student’s t test or
Mann-Whitney U test in case of not normally distrib-
uted data.
For comparison of categorical variables, the chi-square
test or Fisher’s exact tests are used.
The primary analysis focused on modeling the hypoth-
esized relation between ROTEM-detected hypercoagula-
bility, MOF and mortality in trauma patients. First,
univariate logistic regression analysis was used to select
independent factors achieving a P value ≤0.10, in addition
to factors that were deemed clinically important (age, time
to ED, presence of traumatic brain injury, injury mechan-
ism, ISS, base excess, systolic blood pressure) in relation
to the outcome variables. Subsequently, selected ROTEM
factors were entered in a multivariate logistic regression
model. Patients who died on admission were not included
in the analyses to assess the value of thromboelastometry
to predict MOF, while patients who died later were in-
cluded when a SOFA score was available. All deceasedFigure 1 Flow diagram of inclusion and occurrence of multiple organpatients were included in the analyses to assess the value
of ROTEM to predict mortality.
To compare the effect of transfusion strategies, trans-
fused patients were divided based on RBC:FFP ratio.
Statistical significance was considered to be at P = 0.05.
Analyses were performed using R (version 2 · 3; R Founda-
tion for Statistical Computing, Vienna, Austria). Graphs
were created with Prism 5.0 (GraphPad Software, San
Diego, CA, USA).
Results
During the study period, 1,245 patients were screened
and 1,010 patients were enrolled in the study (Figure 1).
For 62 of the patients, no data were available on occur-
rence of MOF or mortality, therefore, analyses were per-
formed in the remaining 948 patients.
Of these, 776 patients were admitted to the hospital
(intensive care unit: n = 318 and ward: n = 458) and 76
were discharged home. Patient characteristics are listed
in Table 1. The majority of included patients were males
experiencing blunt injury. Median age was 38 years and
median ISS was 13 (IQR 8 to 25). Eighteen patients diedfailure and mortality.
Table 1 Characteristics of patients with hyper-, hypo- and normocoagulable ROTEM profiles at admission
All patients Hypercoagulable1 Normocoagulable2 Hypocoagulable3 P value
N = 886 N = 63 N = 752 N = 71
Age (years) 38 [26–53] 44 [33–62] 38 [25–53] 38 [25–54] <0.05
Sex, male % (n) 78 (688) 60 (38) 80 (599) 72 (51) <0.001
Time to ED (minutes) 71 [53–90] 71 [46–86] 70 [53–88] 80 [60–100] 0.05
Trauma mechanism, blunt % (n) 81 (722) 81 (51) 82 (619) 86 (61) 0.69
Brain injury, % (n) 26 (233) 23 (14) 27 (193) 38 (26) 0.09
ISS 13 [6–25] 9 [5–17] 13 [5–25] 20 [10–39] <0.001
Systolic BP, (mmHg)* 131 (30) 136 (28) 131 (29) 122 (34) 0.06
Base excess (mEq/L) −1.4 [−4.0–0.6] −1.3 [−3.2–0.2] −1.2 [−3.7–0.8] −4.3 [−9.5—0.5] <0.001
RBC (units) 5 [3–8] 4 [3–5] 4 [3–8] 6 [4–11] <0.05
FFP (units) 4 [4–8] 3 [2–4] 4 [4–8] 6 [4–13] 0.001
PLT (units) 1 [1–2] 1 [1–1] 1 [1–2] 2 [1–5] <0.01
Cryoprecipitate 2 [2–2] NA 2 [2–2] 2.5 [2–5] 0.06
All variables expressed as median and interquartile ranges [IQR]. *Expressed as mean and standard deviation (SD). 1Hypercoagulable G ≥11.7 dynes/cm2;
2normocoagulable G = 5–11.7 dynes/cm2; 3hypocoagulable G <5 dynes/cm2. ED: emergency department; ISS: injury severity score; BP: blood pressure; RBC: red
blood cell; FFP: fresh frozen plasma; PLT: platelets; NA: not applicable.
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(TBI). Of those who died between 24 hours and 28 days,
mortality was 21% in TBI and 3.4% in non-TBI patients.ROTEM profiles and hypercoagulability on admission
Baseline thromboelastometry data were available for 886
patients upon ED admission. On admission, the G value
was increased in 63 (7%) of the patients, while 71 (8%)
were hypocoagulable and the remaining 85% had normal
clot strength according to the G value. Patients showing
hypercoagulability on admission were more often female
(40% vs. 28%, P <0.001), had lower ISS scores (9 vs. 20,
P <0.001) and higher base excess values (−1.3 mEq/L vs.
−4.3 mEq/L, P <0.001) compared to hypocoagulable pa-
tients. Also, they received less RBC, FFP and platelet
transfusions compared to hypocoagulable patients. In
addition, hypocoagulable patients had longer time to ar-
rival at ED and a trend toward a higher incidence of TBI
(Table 1).ROTEM profiles and hypercoagulability 24 hours after
admission
Twenty-four hours after admission, for 451 out of 776
admitted patients, ROTEM profiles were available, 26
(6%) patients were hypercoagulable and 35 (8%) were
hypocoagulable (Figure S1 in Additional file 1). In ac-
cordance with the hypercoagulable patients at ED ad-
mission, the hypercoagulable patients 24 hours after
admission had lower ISS scores (14 vs. 25, P = 0.04),
higher base excess values (−1.4 mEq/L vs. −6.2 mEq/L,
P <0.001) and received less RBC transfusions compared to
the hypocoagulable patients. Amount of FFP and plateletstransfused did not differ between hyper-, normo- and hypo-
coagulable patients.
Altogether, during the first 24 hours after trauma, 88
(10%) patients were hypercoagulable at some point. Pa-
tients showing hypercoagulable ROTEM profiles had
higher platelet counts and fibrinogen levels (Table S2 in
Additional file 1).
ROTEM profiles and multiple organ failure
Forty-one percent of trauma patients developed MOF
(Figure 1). These patients were older, had higher ISS
scores, more often had brain injury and received more
blood products (Table S1 in Additional file 1). Of patients
who were hyper- or normocoagulable on admission, 40%
developed MOF, compared to 53% of the hypocoagulable
patients. In patients presenting with hypocoagulability, the
worst SOFA scores were higher compared to those who
were normo- or hypercoagulable on admission (P = 0.003,
Figure 2). Also, patients who developed MOF had hypo-
coagulable admission profiles as measured by ROTEM
compared to patients who did not develop MOF (Table 2).
The same picture was noted 24 hours after admission.
The worst median SOFA scores were highest among pa-
tients showing hypocoagulability 24 hours after admission,
indicating more severe organ failure in these patients
(Figure 2).
Conventional coagulation screens also indicated more
hypocoagulable profiles in patients developing MOF
(Table S3 in Additional file 1).
ROTEM profiles and prediction of MOF and mortality
Univariate logistic regression analysis with admission
ROTEM variables identified INTEM CFT, INTEM alpha,
Figure 2 Occurrence of multiple organ failure and the worst
SOFA scores in patients with hypo-, normo- and hypercoagulable
profiles at admission and 24 hours after admission. Gray bars
indicate occurrence of multiple organ failure and black dots indicate
median SOFA scores and interquartile ranges. *P <0.01. **P <0.05. MOF:
multiple organ failure; SOFA: sequential organ failure assessment.
Table 3 Prediction of occurrence of multiple organ failure
by EXTEM ROTEM variables at admission and 24 hours
after admission with multivariate analysis
OR 95% CI P value
Admission
CT 1.01 1.00-1.01 0.05
CFT 0.99 0.99-1.00 0.23
Alpha 0.95 0.92-0.98 <0.01
MCF 1.01 0.98-1.04 0.62
G 0.94 0.89-0.99 0.02
24 hours after admission
CT 1.00 0.00-2.39 0.86
CFT 1.03 1.01-1.04 <0.01
Alpha 1.04 0.95-1.15 0.37
MCF 1.04 0.99-1.09 0.13
G 0.92 0.85-1.00 0.05
OR: odds ratio; CI: confidence interval; CT: clotting time; CFT: clot formation
time; MCF: maximum clot firmness.
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and G to be associated with the occurrence of MOF, as
were trauma characteristics and baseline vital parameters.
After performing multiple logistic regression analysis with
ROTEM variables, admission EXTEM CT, alpha and G
were shown to be predictors for the occurrence of MOF
(Table 3). The odds ratios for MOF indicated that change
of the parameters toward a more hypocoagulable profile
resulted in an increased risk for the development of MOF.
We did not find any correlation between a hypercoagula-
ble profile and the occurrence of MOF.Table 2 Thromboelastometry results at admission of
patients who did and did not develop multiple organ
failure
MOF No MOF P value
N = 381 N = 549
INTEM CT (sec) 138 [115 to 168] 134 [113 to 166] 0.22
INTEM CFT (sec) 80 [63 to 104] 71 [60 to 89] <0.001
INTEM alpha° 74 [70 to 77] 76 [73 to 78] <0.001
INTEM MCF (mm) 60 [56 to 64] 62 [58 to 65] <0.001
EXTEM CT (sec) 59 [49 to 73] 55 [46 to 68] 0.002
EXTEM CFT (sec) 98 [78 to 122] 88 [72 to 105] <0.001
EXTEM alpha° 71 [66 to 75] 73 [69 to 76] <0.001
EXTEM MCF (mm) 60 [56 to 65] 62 [58 to 66] 0.005
EXTEM G (dynes/cm2) 7.5 [6.4 to 9.3] 8.2 [6.9 to 9.7] 0.005
Median and interquartile range [IQR]. MOF: multiple organ failure; CT: clotting
time; CFT: clot formation time; MCF: maximum clot firmness.EXTEM CFT and G were predictors for MOF 24 hours
after admission (Table 3).
The total mortality was 10% (n = 97) (Figure 1). Of
note, patients who were hypercoagulable on admission
had lower 28-day mortality compared to normo- and
hypocoagulable patients (0% in hypercoagulable patients
vs. 7% in normocoagulable and 24% in hypocoagulable
patients, P <0.001). Multivariate analysis with ROTEM
variables showed that low EXTEM alpha angle on ad-
mission was a predictor for mortality (0.95 (0.91 to 0.98)
P <0.01). Every degree increase of the alpha angle results
in a 0.95 reduction of mortality risk.ROTEM profiles, transfusion strategy and occurrence
of MOF
In order to assess whether liberal use of FFP affected oc-
currence of hypercoagulability and subsequent MOF, we
performed an additional subanalysis in patients trans-
fused with RBC and FFP. Transfused patients were di-
vided in one group with an RBC:FFP ratio of 1:1 (n = 35),
one with a ratio of more than 1:1 (n = 115) and one with a
ratio of less than 1:1 (n = 21). These three groups did not
differ significantly with respect to baseline characteristics
(data not shown) and platelet transfusions. ROTEM
EXTEM CT, CFT, MCF and alpha did not differ at base-
line and after 24 hours, nor did G values (data not shown).
After 24 hours, none of the patients transfused with a
RBC:FFP ratio <1:1 showed hypercoagulability and of pa-
tients transfused with higher ratios of RBC:FFP, only two
out of one hundred patients progressed from a normocoa-
gulable to a hypercoagulable state (Figure S2 in Additional
file 1).
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differ between groups with different transfusion ratios
(82% in patients with a ratio of 1:1 or higher, and 81% in
patients with RBC:FFP <1:1 respectively, P = 0.99).
Discussion
The current study shows that a hypercoagulable state as
detected by thromboelastometry, occurred in 7% at ad-
mission and in 10% of patients within 24 hours after
trauma. Characteristics associated with the presence of
hypercoagulability included lower ISS, higher base excess
values, female gender and shorter time to ED arrival.
These rates were not that different to the detected inci-
dence for hypocoagulability, which has been the focus of
considerable research interest, as part of evolving con-
cepts of ATC. In contrast to our hypothesis, hypercoagu-
lability did not appear to predict the occurrence of
MOF. Rather, severity of MOF after trauma was associ-
ated with a hypocoagulable state. Hypercoagulable pa-
tients at admission had lower mortality, consistent with
lower ISS and more normal base excess values. High
EXTEM CFT and low G values were predictive for the
development of MOF and low EXTEM alpha was pre-
dictive for mortality.
Hypercoagulability after trauma has been reported
using a variety of thrombelastographic (TEG) measure-
ments [5,7,9,25,26], however, whether TEG and ROTEM
results are interchangeable is still under debate [27,28].
Reported incidences of hypercoagulability diagnosed by
TEG range from 11 to 80% [5,7,9,10,26]. This wide vari-
ation can be ascribed to use of different definitions of
hypercoagulability, with studies using individual parame-
ters of the thrombelastographic trace [5,9,26], a combin-
ation of parameters [6,10] or the use of G as a marker of
whole clot strength [7]. Also injury severity and timing
of measurements differed among these cohorts. Al-
though our findings are in line with those previously re-
ported in a smaller cohort of trauma patients [26], our
observed rates of hypercoagulability were lower com-
pared to a recent evaluation of admission profiles with
TEG, most likely due to the use of a more narrow defin-
ition of hypercoagulability in this study [9]. With respect
to the observed rate of hypocoagulability, our numbers
were in line with the previous mentioned TEG study [9],
but lower than other reports from the ACIT cohort
using ROTEM [29], because only patients needing more
than four units of RBC were included.
We hypothesized that occurrence of hypercoagulability
was associated with MOF. However, we observed an op-
posite effect. Patients showing hypocoagulability within
the first 24 hours of admission developed more severe
organ failure and had an increased late mortality. This
observation is in line with studies demonstrating that
hypocoagulability is associated with adverse outcomeafter trauma and brain injury [23,30,31]. We showed
that, in addition to individual parameters, G values on
admission and 24 hours after admission are predictors
for the occurrence of MOF. Of note, G is considered to
better represent total clot strength than the individual
thrombelastography parameters [7,16,23]. Previous stud-
ies on ROTEM in trauma patients focused on diagnos-
ing early coagulation abnormalities [20,32], prediction of
transfusion requirements [21,33] and correction of hypo-
coagulability [34,35]. Our data indicate, contrary to our
hypothesis, that hypocoagulability detected by ROTEM
also has an enhanced risk of adverse late outcome,
which confirms previous observations in a smaller co-
hort [21].
In the current study, patients with hypercoagulability
had lower mortality and lower SOFA scores. A similar
observation was recently reported in a smaller cohort of
trauma patients [9]. Therefore, we hypothesize that early
hypercoagulability after trauma is an evolutionary re-
sponse to prevent exsanguination. Results do not point
toward the hypothesis that early hypercoagulability after
trauma resembles disseminated intravascular coagulation
(DIC) with the formation of microthrombi, thereby con-
tributing to organ failure [15,36]. The observation that
early hypercoagulability after trauma is more prevalent
in females is in line with a previous report [5].
Limitations of our study include that we did not sys-
tematically look for occurrence of venous thrombo-
embolism as this is a complication of major interest in
patients initially surviving major trauma. In addition,
only the summary of the SOFA score was collected,
hereby we cannot comment on SOFA subgroups. It is
also not possible to rule out a contribution of late hyper-
coagulability to the development of organ failure, as we
only assessed ROTEM on admission and after 24 hours.
Prolonged hypercoagulability has been linked to in-
creased risk of thromboembolic complications [7,10,11].
Also, we did not assess d-dimers and hereby we were
not able to correlate ROTEM findings to DIC scores.
However, a recent review of pathology samples obtained
early after trauma failed to demonstrate microthrombi
despite the clinical presence of increased DIC scores
[37]. Furthermore, in 40% of admitted patients ROTEM
values were not available at 24 hours following trauma,
attributed to logistic issues, which could have introduced
recruitment bias and contributed to an underestimation
of hypercoagulability at this time point. Limited reports
have described the coagulopathic changes over time in
trauma and a recent small cohort study suggested that
hypercoagulability after trauma occurs after 48 hours
[38]. Therefore, further research should include serial
measurements and a prospective standardized observa-
tion of complications after trauma. However, the current
data suggest that early hypercoagulability after trauma
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associated with lower occurrence and severity of MOF
and 28-day mortality.
Altogether, this study has identified a significant pro-
portion of patients with hypercoagulability as defined by
ROTEM at admission. Further work in larger studies
should define the clinical consequences and prognostic
value of identifying hypercoagulability, specifically in-
cluding thromboembolic events, and might assess a role
for very early, targeted use of anticoagulants in selected
patients. The role of plasma or other blood components
in potentially exacerbating the consequences of hyperco-
agulability is also an area of further research. In this
study, patients with hypocoagulability on admission mostly
tended to regress to normal values over time and not to
hypercoagulability, irrespective of blood product ratio.
This is in contrast with studies showing an association be-
tween amount of blood products and MOF [39], but is in
line with other studies, which suggested that other fluids
were more associated with MOF than blood products
[40,41]. Also, there is experimental evidence that FFP pre-
serves endothelial integrity in hemorrhagic shock [42].
Conclusions
In a cohort of trauma patients, 10% shows a hypercoagula-
ble state, as defined by ROTEM G value, within the first
24 hours. Occurrence of early hypercoagulability is not as-
sociated with development of MOF, moreover it appears
to protect against adverse outcome. Admission ROTEM
variables indicating hypocoagulability are predictive of the
development of MOF and mortality. Liberal use of FFP is
not associated with enhanced hypercoagulability.
Key messages
 Up to 10% of trauma patients show hypercoagulable
ROTEM profiles within the first 24 hours after
admission.
 Hypocoagulable, but not hypercoagulable profiles in
trauma patients, are associated with adverse outcome.
 Further research on the prognostic value of ROTEM
profiles in trauma patients is warranted and should
focus on sequential measurements to further
elucidate coagulation patterns and their influence on
patient outcomes.
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